Cargando…
Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions
BACKGROUND: Typically minor ABO incompatible platelet products are transfused without any incident, yet serious hemolytic transfusion reactions occur. To mitigate these events, ABO ‘low titer’ products are used for minor ABO incompatible transfusions. We sought to understand the role of IgM/IgG and...
Autores principales: | Pandey, Priyanka, Anani, Waseem Q., Pugh, Tina, Gottschall, Jerome L., Denomme, Gregory A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257204/ https://www.ncbi.nlm.nih.gov/pubmed/32466782 http://dx.doi.org/10.1186/s12967-020-02378-w |
Ejemplares similares
-
ABO-incompatible granulocyte transfusion: Is ABO subgroup a barrier?
por: Agrawal, Soma, et al.
Publicado: (2022) -
ABO incompatible renal transplant: Transfusion medicine perspective
por: Makroo, Raj Nath, et al.
Publicado: (2017) -
Lower Levels of ABO Anti-A and Anti-B of IgM, IgG and IgA Isotypes in the Serum but Not the Saliva of COVID-19 Convalescents
por: Matzhold, Eva M., et al.
Publicado: (2022) -
Influence of Transfusion on the Risk of Acute Kidney Injury: ABO-Compatible versus ABO-Incompatible Liver Transplantation
por: Yu, Je Hyuk, et al.
Publicado: (2019) -
ABO-Incompatible Kidney Transplantation
por: Morath, Christian, et al.
Publicado: (2017)